openPR Logo
Press release

Neurotechnology Market Grows at 11.9% CAGR to 2035

12-26-2025 11:35 AM CET | Health & Medicine

Press release from: Expert Market Research

Can Neurotechnology Redefine How We Understand and Treat the Human Brain?

Neurotechnology Market: Global Overview, Trends, and Future Outlook

The Neurotechnology Market stands at the intersection of neuroscience, engineering, and digital innovation, offering transformative solutions for understanding, monitoring, and treating disorders of the nervous system. Neurotechnology encompasses a broad range of tools and devices-such as brain imaging systems, neurostimulation devices, and neurological implants-that interact directly with the brain and nervous system to diagnose, manage, or restore neurological function.

In 2025, the global neurotechnology market reached a value of approximately USD 16.82 billion, driven by the rising prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain. With continuous advancements in brain-computer interfaces (BCIs), neuroimaging, and neuromodulation therapies, the market is expected to grow at a robust CAGR of 11.90% during 2026-2035, reaching USD 51.78 billion by 2035.

Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/neurotechnology-market/requestsample.

What Is Neurotechnology?

Neurotechnology refers to technologies designed to record, analyze, stimulate, or interact with neural activity in the brain and nervous system. These technologies are used across:

Clinical diagnosis (e.g., brain imaging)

Therapeutic intervention (e.g., deep brain stimulation)

Rehabilitation and monitoring

Research and cognitive enhancement

Neurotechnology plays a critical role in improving patient outcomes by enabling earlier diagnosis, personalized treatment, and better disease management.

Neurotechnology Market Overview

The Neurotechnology Market includes products and solutions used in hospitals, clinics, diagnostic centers, and ambulatory surgical centers. Its expansion is driven by:

Increasing neurological disease burden

Aging global population

Rising healthcare expenditure

Rapid technological innovation in neuroscience

As mental and neurological health gain greater global attention, neurotechnology is becoming an essential component of modern healthcare systems.

Key Growth Drivers of the Neurotechnology Market

Rising Prevalence of Neurological Disorders

Neurodegenerative diseases such as Alzheimer's and Parkinson's are increasing worldwide due to aging populations and longer life expectancy. According to global health estimates, neurological disorders are among the leading causes of disability-adjusted life years (DALYs).

Technological Advancements in Brain Imaging and Stimulation

Innovations in functional and structural imaging, as well as minimally invasive neurostimulation devices, are significantly improving diagnostic accuracy and therapeutic outcomes.

Growing Demand for Personalized and Precision Medicine

Neurotechnology enables targeted therapies based on individual neural patterns, supporting the shift toward personalized neurological care.

Expansion of Neurostimulation Therapies

Neurostimulation devices are increasingly used for treating Parkinson's disease, epilepsy, chronic pain, and essential tremor, driving strong market demand.

Increased Investment in Neuroscience Research

Government funding, academic research, and private-sector investment are accelerating innovation in brain-computer interfaces and neural implants.

Emerging Trends Shaping the Neurotechnology Market

Growth of Brain-Computer Interfaces (BCIs)

BCIs allow direct communication between the brain and external devices, offering breakthrough applications in paralysis treatment, prosthetics control, and neurorehabilitation.

Shift Toward Non-Invasive Neurotechnologies

Non-invasive techniques such as transcranial magnetic stimulation (TMS) and electroencephalography (EEG) are gaining popularity due to reduced risks and lower costs.

Integration with Artificial Intelligence

AI-driven analytics are improving interpretation of complex neural data, enhancing diagnostic precision and predictive capabilities.

Rising Adoption in Mental Health and Sleep Disorders

Neurotechnology is increasingly applied to sleep disorders, depression, anxiety, and other mental health conditions.

Miniaturization and Wearable Neurodevices

Compact, wearable neuro-monitoring devices are expanding use cases beyond hospitals into home and remote care settings.

Neurotechnology Market Segmentation Analysis

By Product Type

Imaging Modalities

Imaging technologies form a foundational segment of the neurotechnology market, enabling visualization of brain structure and activity.

Functional Imaging:

Includes fMRI and PET scans that measure brain activity, blood flow, and metabolic processes.

Structural Imaging:

Includes MRI and CT scans used to identify tumors, lesions, and anatomical abnormalities.

Neurostimulation

Neurostimulation devices deliver electrical or magnetic impulses to modulate neural activity. These are widely used in Parkinson's disease, epilepsy, pain treatment, and depression.

Neurological Implants

Implants such as deep brain stimulators and cochlear implants offer long-term therapeutic benefits for severe neurological and sensory disorders.

By Condition

Parkinson's Disease

One of the largest application areas, driven by increasing prevalence and widespread adoption of deep brain stimulation.

Epilepsy

Neurotechnology supports both diagnosis (EEG, imaging) and treatment (neurostimulation), especially in drug-resistant cases.

Pain Treatment

Chronic pain management using spinal cord stimulation and peripheral nerve stimulation is gaining strong traction.

Essential Tremor

Neurostimulation and focused ultrasound technologies are increasingly used to manage tremor symptoms.

Sleep Disorders

Neurodiagnostic tools help identify sleep apnea, insomnia, and circadian rhythm disorders.

Hearing Conditions

Cochlear implants and auditory brainstem implants significantly improve quality of life for individuals with hearing impairments.

Other Conditions

Includes stroke rehabilitation, traumatic brain injury, and psychiatric disorders.

Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/neurotechnology-market.

By End Use

Hospitals:

Primary end users due to advanced infrastructure and high patient volume.

Clinics:

Increasingly adopting neurostimulation and diagnostic tools.

Diagnostic Centres:

Specialized centers focused on imaging and neurodiagnostics.

Ambulatory Surgical Centres:

Growing adoption for minimally invasive neuroprocedures.

Regional Analysis of the Neurotechnology Market

North America

North America dominates the market, supported by advanced healthcare infrastructure, high research spending, and early adoption of innovative neurotechnologies.

Europe

Europe holds a significant share due to strong regulatory frameworks, aging populations, and robust neuroscience research ecosystems.

Asia Pacific

The fastest-growing region, driven by rising neurological disease prevalence, expanding healthcare access, and increasing investments in medical technology.

Latin America

Market growth is supported by improving diagnostic capabilities and gradual adoption of advanced neurotechnologies.

Middle East and Africa

Although still emerging, this region offers long-term growth opportunities as awareness and healthcare investments increase.

Competitive Landscape

The neurotechnology market is moderately consolidated, with global players focusing on innovation, strategic collaborations, and geographic expansion.

Key Companies Covered

Allengers Medical Systems Ltd

Canon Medical Systems Corporation

GE Healthcare Technologies Inc.

Koninklijke Philips N.V.

Natus Medical Incorporated

Siemens Healthcare GmbH

The Magstim Company Limited

Tristan Technologies Inc.

Shimadzu Corporation

Medtronic plc

These companies are investing heavily in R&D to develop next-generation imaging systems, neurostimulation devices, and implants.

Challenges Facing the Neurotechnology Market

Despite strong growth prospects, the market faces several challenges:

High cost of advanced neurotechnology devices

Ethical and regulatory concerns surrounding brain data

Limited access in low- and middle-income countries

Need for highly skilled professionals

Long approval timelines for implantable devices

Addressing these challenges will be critical for broader adoption and equitable access.

Future Outlook: 2026-2035

The future of the Neurotechnology Market is highly promising. Key developments expected over the forecast period include:

Expansion of brain-computer interface applications

Greater use of AI-driven neurodiagnostics

Increased focus on non-invasive and wearable solutions

Rising adoption in mental health and preventive care

Strong growth in emerging economies

With continued innovation and investment, neurotechnology is poised to fundamentally reshape how neurological conditions are diagnosed, treated, and managed.

Discover More Reports

Topical Pain Relief Market - https://bit.ly/4pgyr4n.

Hospital Market - https://bit.ly/4a24kJJ.

North America Clinical Nutrition Market - https://www.linkedin.com/pulse/north-america-clinical-nutrition-market-future-trends-roshan-kumar-xmf1c.

North America Clinical Data Analytics in Healthcare - https://www.linkedin.com/pulse/north-america-clinical-data-analytics-healthcare-forecast-kumar-scm2c.

Media Contact

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurotechnology Market Grows at 11.9% CAGR to 2035 here

News-ID: 4329468 • Views:

More Releases from Expert Market Research

Cardiac Biomarker Testing Market Worth USD 5.09B in 2025
Cardiac Biomarker Testing Market Worth USD 5.09B in 2025
Can Early Cardiac Biomarker Testing Transform the Fight Against Heart Disease? Cardiac Biomarker Testing Market: Global Overview, Trends, and Future Outlook The Cardiac Biomarker Testing Market has become a cornerstone of modern cardiovascular diagnostics, enabling faster, more accurate detection of heart-related conditions and significantly improving patient outcomes. As cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, early diagnosis and timely intervention are critical. Cardiac biomarkers-measurable substances released into the blood
Pegfilgrastim Biosimilars Market to Reach USD 1.22M by 2035
Pegfilgrastim Biosimilars Market to Reach USD 1.22M by 2035
Can Pegfilgrastim Biosimilars Redefine Supportive Cancer Care Worldwide? Pegfilgrastim Biosimilars Market: Global Overview, Trends, and Future Outlook The Pegfilgrastim Biosimilars Market is emerging as a critical component of modern oncology care, driven by the rising global burden of cancer-particularly leukaemia-and the need to reduce the cost of biologic therapies. Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF), plays a vital role in preventing chemotherapy-induced neutropenia, a potentially life-threatening complication that increases infection risk
Hypovolemia Epidemiology Forecast Report 2026-2035
Hypovolemia Epidemiology Forecast Report 2026-2035
Is Hypovolemia Emerging as a Silent Driver of Preventable Mortality Worldwide? Hypovolemia Epidemiology Forecast: Global Burden, Trends, and Outlook (2026-2035) Hypovolemia remains one of the most critical yet often underrecognized medical conditions contributing to acute morbidity and mortality worldwide. Characterized by a significant reduction in circulating blood or plasma volume, hypovolemia can rapidly progress to hypovolemic shock, multi-organ failure, and death if not identified and treated promptly. The Hypovolemia Epidemiology Forecast highlights
Express Delivery Market Size, Growth and Forecast (2026-2035)
Express Delivery Market Size, Growth and Forecast (2026-2035)
The express delivery market plays a crucial role in the modern logistics and e-commerce industries, offering fast and reliable shipping services that help businesses meet tight deadlines and provide customers with near-instant gratification. As consumer demand for faster delivery times continues to rise, express delivery services have become indispensable to industries ranging from retail and healthcare to manufacturing and technology. With its ability to ensure quick and efficient delivery of

All 5 Releases


More Releases for Neurotechnology

Neurotechnology Market Grows to $15.03B, 11.9% CAGR
Why Is the Neurotechnology Market Growing So Rapidly in 2024-2034? The neurotechnology market is growing at a remarkable pace due to rapid advancements in brain imaging, neurostimulation, and neurological implants, along with the rising incidence of neurological diseases worldwide. The market was valued at USD 15.03 Billion in 2024 and is projected to grow at an 11.90% CAGR, reaching USD 46.27 Billion by 2034. Neurological disorders-such as Alzheimer's, Parkinson's, epilepsy, chronic pain
Neurotechnology Market Outlook: Demand Forecast and Future Growth (2034)
The neurotechnology market is undergoing significant growth, driven by the increasing prevalence of neurological disorders, growing technological innovations, and rising global demand for advanced diagnostic and therapeutic tools. In 2024, the global neurotechnology market was valued at USD 15.03 Billion, and it is expected to grow at a CAGR of 11.90% during the forecast period from 2025 to 2034, reaching approximately USD 46.27 Billion by 2034. Get a free sample report:
Global Neurotechnology Device Market Research Report 2023
The global Neurotechnology Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. The neurotechnology device market refers to the industry involved in the manufacturing, sales, and distribution of medical devices and technologies that interface with the nervous system
Neurotechnology Market To Scale Through Technological Disruptions
The global Neurotechnology Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely feedback. This
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Peptone Market to Be Driven By Neurotechnology
The Peptone Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to professionals bringing